Age-Related Macular Degeneration (AMD): Counseling on Antioxidant Supplement
-
Percentage of patients aged 50 years and older with a diagnosis of age-related macular degeneration or their caregiver(s) who were counseled within 12 months on the benefits and/or risks of the AREDS formulation for preventing progression of AMD
CBE ID0566